Humana (NYSE:HUM) Stock Price Down 0.1%

Shares of Humana Inc. (NYSE:HUM) traded down 0.1% during mid-day trading on Friday . The company traded as low as $316.60 and last traded at $320.80. 404,774 shares traded hands during mid-day trading, a decline of 80% from the average session volume of 1,974,901 shares. The stock had previously closed at $320.98.

Wall Street Analyst Weigh In

HUM has been the topic of several recent analyst reports. Argus downgraded Humana from a “buy” rating to a “hold” rating in a research note on Wednesday, March 13th. The Goldman Sachs Group dropped their price target on shares of Humana from $450.00 to $385.00 and set a “buy” rating on the stock in a research report on Wednesday, April 3rd. Jefferies Financial Group cut their price objective on Humana from $411.00 to $381.00 and set a “buy” rating for the company in a research report on Monday, April 22nd. Mizuho reduced their price objective on Humana from $550.00 to $400.00 and set a “buy” rating for the company in a research note on Friday, January 26th. Finally, Bank of America reaffirmed a “neutral” rating and issued a $342.00 price target (down from $470.00) on shares of Humana in a research note on Tuesday, April 2nd. Eleven analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $424.50.

Humana Stock Performance

The stock has a fifty day moving average price of $324.67 and a 200-day moving average price of $389.56. The firm has a market capitalization of $38.63 billion, a price-to-earnings ratio of 19.96, a PEG ratio of 1.83 and a beta of 0.49. The company has a current ratio of 1.67, a quick ratio of 1.67 and a debt-to-equity ratio of 0.77.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 EPS for the quarter, beating the consensus estimate of $6.12 by $1.11. Humana had a net margin of 1.82% and a return on equity of 17.76%. The company had revenue of $29.61 billion for the quarter, compared to the consensus estimate of $28.52 billion. During the same quarter in the previous year, the company earned $9.38 EPS. The firm’s revenue for the quarter was up 10.7% compared to the same quarter last year. As a group, analysts anticipate that Humana Inc. will post 16.18 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.10%. The ex-dividend date of this dividend is Friday, June 28th. Humana’s dividend payout ratio (DPR) is currently 22.04%.

Insider Buying and Selling

In other Humana news, Director Jorge S. Mesquita acquired 545 shares of the business’s stock in a transaction on Tuesday, February 20th. The stock was purchased at an average price of $367.09 per share, for a total transaction of $200,064.05. Following the transaction, the director now owns 2,578 shares in the company, valued at approximately $946,358.02. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.32% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Humana

Institutional investors have recently modified their holdings of the stock. Dorsey & Whitney Trust CO LLC lifted its position in shares of Humana by 2.6% in the third quarter. Dorsey & Whitney Trust CO LLC now owns 817 shares of the insurance provider’s stock valued at $397,000 after buying an additional 21 shares during the last quarter. First Financial Corp IN lifted its holdings in Humana by 7.2% during the 4th quarter. First Financial Corp IN now owns 343 shares of the insurance provider’s stock valued at $157,000 after purchasing an additional 23 shares during the last quarter. First Trust Direct Indexing L.P. boosted its position in Humana by 0.8% during the third quarter. First Trust Direct Indexing L.P. now owns 2,926 shares of the insurance provider’s stock worth $1,424,000 after purchasing an additional 24 shares during the period. Nvwm LLC raised its position in shares of Humana by 41.0% in the third quarter. Nvwm LLC now owns 86 shares of the insurance provider’s stock valued at $42,000 after purchasing an additional 25 shares during the period. Finally, Aurora Investment Counsel boosted its stake in Humana by 1.3% in the 4th quarter. Aurora Investment Counsel now owns 2,273 shares of the insurance provider’s stock valued at $1,155,000 after purchasing an additional 29 shares during the period. 92.38% of the stock is owned by institutional investors.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.